March 23, 2017
Futura medical decreases loss in 2016
Futura medical, healthcare company focused on advanced transdermal technology, has announced its preliminary results for the year 2016.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Futura Medical
March 6, 2017
Futura to extend patent for its impotence treatement for 20 years
Futura Medical has filed a new formulation patent for its topical gel for the treatment of erectile dysfunction, with the UK Intellectual Property Office in connection with MED2002.
January 11, 2017
Director Jonathan Freeman’s Dealings
Futura Medical, the innovative healthcare company focused on advanced transdermal technology has been notified that on 10 January 2017, Jonathan…
January 10, 2017
Futura Medical nets licensing deal with STADA for its pain relief gel
Futura Medical (Futura) has signed a licensing agreement with the UK subsidiary of STADA Arzneimittel AG (STADA), for the commercialisation of TPR100, its pain relief gel.
January 5, 2017
Futura Medicals launches condom in Saudi Arabia, expects further distribution in MENA
Transdermal technology specialist Futura Medicalis has made an – at least to say – interesting step in Saudi Arabia, country…
October 28, 2016
Futura to produce extended shelf life condoms
Futura Medical has gotten EU approval to manufacture CSD500, the company’s novel, erectogenic condom
November 24, 2015
Futura Medical’s two painkillers cleared path for Europe
Futura Medical, a transdermal technology specialist, has received by an European regulator clarity on the regulatory pathways for its two topical pain relief products, TPR100 (diclofenac) and TIB200 (ibuprofen).
November 17, 2015
Two hundred patients for Futura Medical’s MED2002 ED gel study
Futura Medical’s pivotal efficacy study of MED2002, a novel gel for the treatment of erectile dysfunction (ED) is underway and recruitment of patients for the study is proceeding well, with 118 patients having enrolled in the study to date.
October 14, 2015
Quantum Pharma:Licensing Agreement with Futura Medical
Quantum Pharma Plc has announced that it had signed an exclusive agreement with Futura Medical plc the healthcare company which is focused on advanced transdermal technology, to manufacture and make available MED2002, Futura’s novel treatment for erectile dysfunction, as an unlicensed medicine (special) in the UK (the “Agreement”).